David J. Vachon

Dave Vachon is the CEO and Founder of Iasis Molecular Sciences LLC, Spokane, in 2008 and Novion Technologies in 2011. Novion has pioneered a family of technologies aimed at minimizing health care-acquired implantable medical device-related infection; wound infections associated with surgeries, and for the treatment of infections and tissue loss associated with chronic wounds and burn trauma. Areas of focus include topical formulation development for skin diseases, hard to manage wounds, transcutaneous devices; burn wound healing and periodontal disease. Vachon has been awarded four Phase I SBIR grants from the National Institutes of Health and was awarded an Applied Research and Advanced Technology Development Award from the U.S. Army. Vachon has filed three patent applications related to Iasis drug delivery, infection control, and would healing technology. In addition, he was awarded a Phase I SBIR grant for the work of Novion Technologies, and co-investigators from Virginia Commonwealth University and the University of Akron, on topical treatment of burn wound infection. Dave received his Bachelors of Science degree in Chemistry from Framingham State College in Framingham, MA, and earned his PhD in Organic Chemistry from the University of New Hampshire, Durham, NH. Dave was a Postgraduate Research Fellow at the University of California, Santa Barbara Institute for Polymers and Organic Solids, and received a master's in business administration (marketing, finance and business planning) from California State University, Northridge, CA. Dave’s comprehensive understanding of medical device and pharmaceutical markets and technological trends have been key to his obtaining over $4 million in federal funding for Iasis-related technology development. Spokane County Appointee 2nd Term: 2.04.15 – 2.04-19